CEL-SCI’s LEAPS Peptides Demonstrate Clear Survival Benefit as a Treatment for COVID-19 in Preclinical Studies
Rankings by 
National Ranking
210th
in United StatesRegional Ranking
230th
in North America and CaribbeanGlobal Ranking
577th
worldwide